Rachele Alzani
- Oncology top 10%
- Cancer-related Molecular Pathways 7
- CAR-T cell therapy research 4
-
- Chronic Lymphocytic Leukemia Research 3
- Glioma Diagnosis and Treatment 3
-
- Immune Cell Function and Interaction 4
-
- Monoclonal and Polyclonal Antibodies Research 6
-
- Glycosylation and Glycoproteins Research 3
-
- Neuroblastoma Research and Treatments 3
- Co-authors
- Veronica PattonEnrico PesentiEmanuele CozziFabrizio MarcucciAngelo CortiMarina CiomeiAnna DegrassiPietro Ghezzi
- Cited by
- OncologyGeneticsImmunology
- Journals
- Cytotherapy (3 papers)Molecular Cancer Therapeutics (2 papers)The Journal of Immunology (2 papers)
- Partner nations
- ItalyUnited StatesMyanmar
In The Last Decade
Rachele Alzani
26 papers receiving 579 citations
Peers
Comparison fields: 5 of 73
- Oncology 256
- Genetics 78
- Immunology 120
- Cell Biology 89
- Cancer Research 67
Countries citing papers authored by Rachele Alzani
This map shows the geographic impact of Rachele Alzani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachele Alzani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachele Alzani more than expected).
Fields of papers citing papers by Rachele Alzani
This network shows the impact of papers produced by Rachele Alzani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachele Alzani. The network helps show where Rachele Alzani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rachele Alzani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 17 | |
| 2 | 2021 | 4 | |
| 3 | 2018 | 14 | |
| 4 | 2017 | 30 | |
| 5 | 2014 | 50 | |
| 6 | 2014 | 24 | |
| 7 | 2013 | 30 | |
| 8 | 2010 | 51 | |
| 9 | 2010 | 11 | |
| 10 | 2010 | 30 | |
| 11 | 2010 | 1 | |
| 12 | 2009 | 80 | |
| 13 | 1995 | 28 | |
| 14 | 1993 | 53 | |
| 15 | 1992 | 2 | |
| 16 | 1992 | 24 | |
| 17 | 1988 | 1 | |
| 18 | 1988 | 11 | |
| 19 | 1988 | 7 | |
| 20 | 1987 | 32 |
About Rachele Alzani
Rachele Alzani is a scholar working on Genetics, Oncology, Immunology and Allergy, Toxicology and Immunology, having authored 26 papers that have together received 589 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (4 papers), Glycosylation and Glycoproteins Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Glioma Diagnosis and Treatment (3 papers) and Neuroblastoma Research and Treatments (3 papers). The work is most often cited by research in Oncology (256 citations), Genetics (78 citations), Immunology (120 citations), Cell Biology (89 citations) and Cancer Research (67 citations). Rachele Alzani has collaborated with scholars based in Italy, United States and Myanmar. Frequent co-authors include Veronica Patton, Enrico Pesenti, Emanuele Cozzi, Fabrizio Marcucci, Angelo Corti, Marina Ciomei, Anna Degrassi, Pietro Ghezzi, Clara Albanese and Roberta Ceruti. Their work appears in journals such as Cytotherapy, Molecular Cancer Therapeutics, The Journal of Immunology, Investigational New Drugs and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.